Biotech & Big Bets: What’s Next for AI-Driven Healthcare with Marisa Krummrich, b2venture

In this episode of The Influencers, Marisa Krummrich, Investment Manager at b2venture, dives into the fast-evolving world of AI, biotech, and venture capital with Hogan Lovells host Leo von Gerlach. Marisa shares the evolution of her groundbreaking tech biomarket map that charts AI’s transformative role in drug discovery and development, and shares insights on what makes a biotech startup truly investable. From accelerating drug development timelines to the unique challenges and opportunities for European startups, this conversation offers a fascinating glimpse into the future of AI-driven healthcare innovation. About b2venture and Marisa Krummrich:  b2venture is a European venture firm, leveraging the power of generations to shape tomorrow, where Marisa focuses on horizontal AI, AI tooling, and vertical enterprise applications that utilize AI as the key enabler. About Hogan Lovells: Our Digital Transformation offering helps clients navigate the full breadth and depth of the seismic forces impacting their organizations – and today’s society. Leveraging team members across our 2800 lawyers on six continents, we provide integrated advice on the multifaceted regulatory, governance and enforcement issues and risks that arise across the many technologies and trends that comprise the new digital future. If you enjoyed today's episode, we'd love for you to rate and review us. Your feedback helps us reach more listeners and continue bringing insightful conversations on digital transformation and law. Thank you for your support!